A pragmatic clinical risk score for adverse outcomes in hypertrophic cardiomyopathy using routine laboratory and bedside variables

Zi-Yi Chen, Jian-Hai Chen · 2026

Read A pragmatic clinical risk score for adverse outcomes in hypertrophic cardiomyopathy using routine laboratory and bedside variables by Zi-Yi Chen, Jian-Hai Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13520300.txt.

Description

Zi-Yi Chen and Jian-Hai Chen introduce in 2026 a bedside risk score for people with hypertrophic cardiomyopathy, a condition where heart muscle grows too thick. Their score uses routine clinic, laboratory and heart-scan measures to estimate the chance of a serious event within one year.

The team followed 1,200 Chinese adults seen between 2015 and 2024, and 120 reached the combined outcome. Ten items form the score, including age, fainting, wall thickness and a blood marker called NT-proBNP. Event rates rose sharply from low to high score bands. The authors warn that heart failure admissions drove most events, so the score should not replace dedicated sudden-death tools.

Catalog record

CREATORZi-Yi Chen, Jian-Hai Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53613
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13520300

Browse the full library · About the Tower of Babel